33 results
6-K
EX-99.1
OBSVF
ObsEva SA
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
at (866)803-9204; from Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY, 10010, by telephone … at (800)221-1037, or bye-mail at newyork.prospectus@credit-suisse.com; or from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520
6-K
EX-99.2
OBSVF
ObsEva SA
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY, 10010, by telephone at (800)221-1037, or bye-mail … atnewyork.prospectus@credit-suisse.com; or from Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, 2nd Floor, New York, NY 10022
6-K
EX-99.1
OBSVF
ObsEva SA
7 Jul 20
Current report (foreign)
3:39pm
Professor and Chair, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, New Haven, Connecticut 23
Focused … for Integrated Research in Musculoskeletal Ageing Healthy Lifespan Institute Mellanby Centre for Bone Research, Department of Oncology & Metabolism University
F-1
EX-10.2
OBSVF
ObsEva SA
30 Dec 16
Registration statement (foreign)
12:00am
) governmental or quasi-governmental authority of any nature (including any governmental division, subdivision, department, agency, bureau, branch, office …
Switzerland
Facsimile: [*]
With a copy to:
Merck Serono S.A.
Zone Industrielle de l’Ouriettaz
1170 Aubonne
Switzerland
Attn: Legal Department
DRS
EX-10
OBSVF
ObsEva SA
14 Oct 16
Draft registration statement
12:00am
) governmental or quasi-governmental authority of any nature (including any governmental division, subdivision, department, agency, bureau, branch, office …
Switzerland
Facsimile: [*]
With a copy to:
Merck Serono S.A.
Zone Industrielle de l’Ouriettaz
1170 Aubonne
Switzerland
Attn: Legal Department
6-K
EX-99.2
jz5mvmma
10 Dec 19
ObsEva Announces Positive Results from Uterine Fibroids Phase 3 Study (PRIMROSE 2) of Linzagolix
12:00am
6-K
47zpi3spwaj kz2
17 May 22
Index to Unaudited Condensed Consolidated Financial Statements
7:00am
DRS
EX-10
p8olhva8 13d
14 Oct 16
Draft registration statement
12:00am
F-1
EX-10.1
4pz0 w0if3sz9lyc93
30 Dec 16
Registration statement (foreign)
12:00am
6-K
4um6hci
1 Dec 22
Index to Unaudited Condensed Consolidated Financial Statements
4:15pm
6-K
EX-1.1
8szy9pdht jeh
22 Jun 18
ObsEva Announces Launch of ProposedFollow-on Public Offering
4:06pm
20-F
tnr g3zrbscov46mige
21 Apr 17
Annual report (foreign)
12:00am
6-K
EX-1.1
0c4ouob y0sk2
8 Sep 20
ObsEva Announces $20.0 Million Underwritten Offering and Concurrent Private Placement
7:40am
6-K
EX-99.1
jmauwoeeq 7ddti5
7 Aug 19
Current report (foreign)
7:21am
F-1
ltd jdkih18gt
30 Dec 16
Registration statement (foreign)
12:00am